Results
1 -
6 of
6Release of methyl isocyanate from the antitumor agent caracemide (NSC-253272), Investigational New Drugs Phase I study and pharmacokinetics of caracemide (NSC-253272) administered as a short infusion, Investigational New Drugs A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer, Investigational New Drugs Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma, Investigational New Drugs Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil, Investigational New Drugs A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer, Investigational New Drugs